micro News and Research

RSS

Researchers elucidate function of Codanin-1 protein

Within all our cells lies two meters of DNA, highly ordered in a structure of less than 10 micro meters in diameter. Special proteins called histones act as small building bricks, organising our DNA in this structure. Preservation of the structure is necessary to maintain correct function of our genes, making histones detrimental for maintaining a healthy and functional body.

13 Mar 2012

Thermo Fisher launches three new capillary ion chromatography columns

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced three new high-capacity, high-efficiency 4 µm particle-size capillary IC columns that enable faster, more accurate analyses.

From Thermo Fisher Scientific Inc. 13 Mar 2012

Exposure to MSS could help reduce cardiorespiratory events in preterm infants

When babies are born prematurely, they are thrust into a hospital environment that while highly successful at saving their lives, is not exactly the same as the mother's womb where ideal development occurs. The Neonatal Intensive Care Unit (NICU) is equipped with highly skilled care givers and incubators that regulate temperature and humidity, but Amir Lahav, ScD, PhD, director of the Neonatal Research Lab at Brigham and Women's Hospital (BWH) thought that something was missing - simulation of the maternal sounds that a baby would hear in the womb.

8 Mar 2012

Ivantis initiates enrollment in Hydrus Microstent study for open angle glaucoma

Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The Hydrus Microstent is the world's first intracanalicular scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldwide and approximately 3 million people in the United States.

6 Mar 2012

New link between polyamine regulation and ESC biology

A*STAR scientists have for the first time, identified that precise regulation of polyamine levels is critical for embryonic stem cell (ESC) self-renewal - the ability of ESCs to divide indefinitely - and directed differentiation.

2 Mar 2012

Language barriers could deter Californians from enrolling in Health Benefit Exchange

Language barriers could deter more than 100,000 Californians from enrolling in the Health Benefit Exchange, according to a study released today by the California Pan-Ethnic Health Network, the UCLA Center for Health Policy Research, and the UC Berkeley Center for Labor Research and Education.

1 Mar 2012

Unknown facets of biological mechanism that immune cells use for creating free radicals

Sometimes our immune defence attacks our own cells. When this happens in the brain we see neurodegenerative diseases such as dementia, Alzheimer's and Parkinson's disease. But if the the immune defence is inhibited, the results could be disastrous.

23 Feb 2012

U.S. Surgeon General, SEMBC join to launch Fighting D in the D campaign

In her advocacy for effective disease prevention and health promotion programs, U.S. Surgeon General Regina M. Benjamin, M.D., joined the Southeast Michigan Beacon Community (SEMBC) today to launch the "Fighting D in the D" campaign during a kickoff event, attended by over 225 guests, at the Westin Book Cadillac in downtown Detroit.

23 Feb 2012

Elekta's Fraxion integrates all proven cranial immobilization options in a single solution

The Fraxion head frame helps ensure accuracy and precision in stereotactic radiation therapy (SRT) of cancer targets in the brain and cranium. Elekta's Fraxion is the first to introduce an innovative system that integrates all proven cranial immobilization options in a single solution.

From Elekta 18 Feb 2012

Cancer cell communication signals may contain pieces of RNA

Researchers have shown that the communication signals sent around the body by cancer cells, which are essential for the cancer to grow, may contain pieces of RNA - these substances, like DNA, are pieces of genetic code that can instruct cells, and ultimately the body, how to form. The same study also found early indications that these genetic instructions can be intercepted and modified by chemotherapy to help prevent cancer cells growing.

16 Feb 2012

Diffusion opens enrollment for TSC clinical trial for newly diagnosed primary brain cancer

Diffusion Pharmaceuticals LLC announced today that it has opened for enrollment a clinical trial testing the company's lead drug candidate trans sodium crocetinate (TSC) as a first-line treatment for newly diagnosed primary brain cancer, also known as glioblastoma or GBM.

13 Feb 2012

Researchers discover molecules that differentiate early-stage breast tumors from invasive cancer

Researchers have discovered a restricted pattern of molecules that differentiate early-stage breast tumors from invasive, life-threatening cancer. They also found a similar molecular signature that correlated with the aggressiveness of invasive tumors, and with the time to metastasis and overall survival.

8 Feb 2012

Researchers learn how to improve performance of microcantilever sensors

Researchers have learned how to improve the performance of sensors that use tiny vibrating microcantilevers to detect chemical and biological agents for applications from national security to food processing.

8 Feb 2012

Wolters Kluwer Health, Laerdal Medical announce product and distribution alliance

Laerdal Medical and Wolters Kluwer Health announced today a product and distribution alliance that will transform healthcare education.

From Laerdal 31 Jan 2012

Murata completes acquisition of VTI

Murata Manufacturing Co., Ltd. announced it has completed the acquisition of VTI Technologies Oy by Murata Electronics Europe B.V., a full subsidiary of Murata Manufacturing Co., Ltd. on January 30th.

31 Jan 2012

Leprosy pathogen exploits micro-RNAs to weaken immune response

A team of UCLA scientists has found that the pathogen that causes leprosy has a remarkable ability to avoid the human immune system by inhibiting the antimicrobial responses important to our defenses.

30 Jan 2012

Novel nano-carrier platform shows promise for cancer drug delivery

A new class of nanoparticles, synthesized by a UC Davis research team to prevent premature drug release, holds promise for greater accuracy and effectiveness in delivering cancer drugs to tumors. The work is published online in Angewandte Chemie, a leading international chemistry journal.

20 Jan 2012

Hawaii surgeons successfully implant FDA-approved eye telescope for AMD

A team of surgeons from Hawaii, Dr. Michael Bennett of Retina Institute of Hawaii and Dr. Michael McMann of McMann Institute, has successfully implanted the FDA-approved eye telescope, a first in Hawaii, at one of the leading medical centers in Honolulu.

19 Jan 2012

BJALCF receives $1 million in grants for 2012 Lung Cancer Research

Just two months shy of marking its 7-year anniversary, BJALCF announced today that it has awarded over $1 million in grants for 2012 Lung Cancer Research. BJALCF has made a promise to the Lung Cancer Community to fund only immediate results-oriented projects or programs promising to catalyze progress through early detection, genetic testing, drug discovery and patient-focused outcomes.

17 Jan 2012

IBM's non-contact, microfluidic, silicon probe minimizes patient discomfort

IBM scientists have developed a flexible, non-contact microfluidic probe made from silicon that can aid researchers and pathologists to investigate critical tissue samples accurately for drug discovery and disease diagnostics.

13 Jan 2012